Nu Skin Enterprises Inc. (NUS) Stock
NYQ · NUS
4.65
Fundamentals
Market cap
$225.37M
Price / Earnings ratio
-1.0x
Price / Sales ratio
0.2x
Price / Book ratio
0.4x
Return on assets
4.0%
Ex-Dividend date
28 Aug 2026
Last payment date
9 Sep 2026
Dividend amount
$0.06
Dividend yield
5.18%
Debt / Equity ratio
N/A
Recent news

Business Wire
Nu Skin Ranked the World's #1 Company for Beauty and Wellness Device Systems for Third Consecutive Year
NeutralNUSSeptember 3, 2026
Business WireNeutral
Nu Skin Ranked the World's #1 Company for Beauty and Wellness Device Systems for Third Consecutive Year
NUS

Zacks Investment Research
Nu Skin Enterprises Q2 Earnings Meet Estimates, Revenues Down Y/Y
NeutralNUSAugust 11, 2026
Zacks Investment ResearchNeutral
Nu Skin Enterprises Q2 Earnings Meet Estimates, Revenues Down Y/Y
NUS

MarketBeat
Nu Skin Enterprises Q2 Earnings Call Highlights
NeutralNUSAugust 11, 2026
MarketBeatNeutral
Nu Skin Enterprises Q2 Earnings Call Highlights
NUS

Zacks Investment Research
Nu Skin Enterprises (NUS) Matches Q2 Earnings Estimates
NeutralNUSAugust 10, 2026
Zacks Investment ResearchNeutral
Nu Skin Enterprises (NUS) Matches Q2 Earnings Estimates
NUS
Technicals
OscillatorsSell5 Indicators
Moving AveragesStrong Sell12 Indicators
Analyst Ratings
Strong Sell0
Sell0
Neutral0
Buy0
Strong Buy0
Financials
Performance
Revenue
Net income
Net margin %
2025
2B1B588M0
Debt & Balance Sheet
Total assets
Total liabilities
2025
2B1B557M0
Revenue to Profit
2025$1.5B
Revenue$0.0
Cost of revenue$0.0
Gross profit$0.0
Operating expenses$160.2M
Net incomeEarnings
No data available
% positive news of 10 articles
published over the past 14 days
Latest news

Business Wire
Nu Skin Ranked the World's #1 Company for Beauty and Wellness Device Systems for Third Consecutive Year
NeutralNUSSeptember 3, 2026
Business WireNeutral
Nu Skin Ranked the World's #1 Company for Beauty and Wellness Device Systems for Third Consecutive Year
NUS

Zacks Investment Research
Nu Skin Enterprises Q2 Earnings Meet Estimates, Revenues Down Y/Y
NeutralNUSAugust 11, 2026
Zacks Investment ResearchNeutral
Nu Skin Enterprises Q2 Earnings Meet Estimates, Revenues Down Y/Y
NUS

MarketBeat
Nu Skin Enterprises Q2 Earnings Call Highlights
NeutralNUSAugust 11, 2026
MarketBeatNeutral
Nu Skin Enterprises Q2 Earnings Call Highlights
NUS

Zacks Investment Research
Nu Skin Enterprises (NUS) Matches Q2 Earnings Estimates
NeutralNUSAugust 10, 2026
Zacks Investment ResearchNeutral
Nu Skin Enterprises (NUS) Matches Q2 Earnings Estimates
NUS

Business Wire
Nu Skin Enterprises Reports Second Quarter Results
NeutralNUSAugust 10, 2026
Business WireNeutral
Nu Skin Enterprises Reports Second Quarter Results
NUS

Business Wire
Nu Skin Enterprises Announces Quarterly Dividend
NeutralNUSAugust 10, 2026
Business WireNeutral
Nu Skin Enterprises Announces Quarterly Dividend
NUS

Business Wire
Nu Skin Enterprises to Announce Second Quarter 2026 Financial Results
NeutralNUSJuly 21, 2026
Business WireNeutral
Nu Skin Enterprises to Announce Second Quarter 2026 Financial Results
NUS

Zacks Investment Research
5 Undervalued Stocks With Attractive Price-to-Sales Ratios
NeutralNUSJune 30, 2026
Zacks Investment ResearchNeutral
5 Undervalued Stocks With Attractive Price-to-Sales Ratios
NUS

Zacks Investment Research
5 Beauty & Cosmetics Stocks to Buy for a Stable Portfolio in 2H 2026
NeutralNUSJune 30, 2026
Zacks Investment ResearchNeutral
5 Beauty & Cosmetics Stocks to Buy for a Stable Portfolio in 2H 2026
NUS

Zacks Investment Research
Nu Skin (NUS) Soars 6.9%: Is Further Upside Left in the Stock?
NeutralNUSJune 29, 2026
Zacks Investment ResearchNeutral
Nu Skin (NUS) Soars 6.9%: Is Further Upside Left in the Stock?
NUS
About Nu Skin Enterprises Inc.
Nu Skin Enterprises Inc is a health and beauty direct-selling company. It has two primary product categories: beauty products and wellness products. The company develops and distributes nutritional, weight-management products, and food supplements under the Nu Skin and Pharmanex brands, respectively. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.
SectorConsumer Defensive
IndustryHousehold & Personal Products
Employees2,800
CEOMr. Ryan S. Napierski
IPO DateNov 21, 1996
HeadquartersProvo, UT
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Steven J. Lund J.D. | Co-Founder & Executive Chairman of the Board | 1953 |
| Mr. Ryan S. Napierski | President, CEO & Director | 1974 |
| Mr. Chayce David Clark | Executive VP, COO & Chief Legal Officer | 1983 |
| Mr. Justin S. Keisel | Executive VP & President of Global Sales (Leave of Absence) | 1974 |
| Mr. Blake M. Roney | Founder | 1959 |
| Ms. Sandra N. Tillotson | Founder | 1957 |
| Ms. Chelsea Lantz | Chief Financial Officer | 1984 |
| Mr. Joe Sueper | Senior VP & CTO | — |
| Dr. Joseph Y. Chang Ph.D. | Executive VP, Chief Scientific Officer & Chair of Scientific Advisory Board | 1953 |
| Mr. B.G. Hunt | VP of Treasurer, Investor Relations & Admin Services | — |
Fundamentals
Valuation
Market cap$225.37M
Price-to-sales ratio0.16
Price-to-book value0.41
Price-earnings ratio-1.00
Return on Equity7.00%
Return on Sales6.00%
Return on Assets4.00%
PEG ratio0.78
Earnings Per Share
Earnings Per Share$-4.44
Income Statement
Average volume537,133
EBITDA$155.75M
1 year high (52w)$12.59
1 year low (52w)$4.49
Dividend
Ex dividend date28 Aug 2026
Dividend amount$0.06
Dividend yield5.18%
Last payment date9 Sep 2026
Dividend yield (TTM)3.87%
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A
Technicals
OscillatorsSell5 Indicators
Moving AveragesStrong Sell12 Indicators
What the experts say
0 Wall Street Analyst Ratings
N/A
0% Buy
0% Hold
0% Sell
Target price
$0.00
Est return
0.00%
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -0.8 | -3.2 | +7.6 | +17.7 | ||||||||
| 2022 | -8.0 | -9.1 | +5.9 | -12.7 | +4.9 | -7.4 | -2.7 | -8.1 | -18.0 | +11.8 | +6.5 | +3.2 |
| 2023 | +1.5 | -10.0 | -3.4 | -2.4 | -16.8 | -1.2 | -12.4 | -19.7 | -11.6 | -8.5 | -8.6 | +10.6 |
| 2024 | -8.7 | -33.8 | +9.4 | -12.8 | +12.8 | -22.1 | +0.0 | |||||
| 2026 | -14.9 | -9.9 | -0.8 | -19.5 | -6.2 | -1.1 | -9.1 | +1.3 |
Corporate actions
Upcoming
No upcoming corporate actions for NUS
Past
DividendQ3/26
Ex-dividend date28 Aug 2026
Payable date9 Sep 2026
Amount per share$0.06
DividendQ2/26
Ex-dividend date29 May 2026
Payable date10 Jun 2026
Amount per share$0.06
DividendQ1/26
Ex-dividend date27 Feb 2026
Payable date11 Mar 2026
Amount per share$0.06



